SXS Spectris Plc

TIDMSXS

RNS Number : 6598D

Spectris PLC

28 April 2017

Spectris plc

CHAIRMAN TO TAKE MEDICAL LEAVE OF ABSENCE

28 April 2017 - The Board of Spectris plc ('Spectris') (LSE: SXS), the productivity-enhancing instrumentation and controls company, announces that Dr John Hughes, non-executive Chairman, has taken leave of absence in order to undergo medical treatment. Russell King, Senior Independent Director, will assume the Chair until John's return or the appointment of his successor on completion of the recruitment process which was announced on 5 December 2016.

- ENDS -

Contacts:

 
 Spectris plc 
  Siobhán Andrews, 
  Head of Corporate Affairs    +44 1784 470470 
 
 FTI Consulting 
  Richard Mountain/Susanne 
  Yule                         +44 203 727 1340 
 

ABOUT SPECTRIS

Spectris plc is a leading supplier of productivity-enhancing instrumentation and controls. The Company's products and technologies help customers to improve product quality and performance, improve core manufacturing processes, reduce downtime and wastage and reduce time to market. Its global customer base spans a diverse range of end user markets. Spectris operates across four business segments which reflect the applications and industries it serves: Materials Analysis, Test and Measurement, In-line Instrumentation and Industrial Controls. Headquartered in Egham, Surrey, United Kingdom, the Company employs around 8,900 people with offices in more than 30 countries. For more information, visit www.spectris.com (http://www.spectris.com).

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSEWSWAFWSESL

(END) Dow Jones Newswires

April 28, 2017 03:11 ET (07:11 GMT)

Spectris (LSE:SXS)
Historical Stock Chart
From Apr 2024 to May 2024

Spectris (LSE:SXS)
Historical Stock Chart
From May 2023 to May 2024